Cargando…
High-throughput cancer hypothesis testing with an integrated PhysiCell-EMEWS workflow
BACKGROUND: Cancer is a complex, multiscale dynamical system, with interactions between tumor cells and non-cancerous host systems. Therapies act on this combined cancer-host system, sometimes with unexpected results. Systematic investigation of mechanistic computational models can augment tradition...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6302449/ https://www.ncbi.nlm.nih.gov/pubmed/30577742 http://dx.doi.org/10.1186/s12859-018-2510-x |
_version_ | 1783381981883531264 |
---|---|
author | Ozik, Jonathan Collier, Nicholson Wozniak, Justin M. Macal, Charles Cockrell, Chase Friedman, Samuel H. Ghaffarizadeh, Ahmadreza Heiland, Randy An, Gary Macklin, Paul |
author_facet | Ozik, Jonathan Collier, Nicholson Wozniak, Justin M. Macal, Charles Cockrell, Chase Friedman, Samuel H. Ghaffarizadeh, Ahmadreza Heiland, Randy An, Gary Macklin, Paul |
author_sort | Ozik, Jonathan |
collection | PubMed |
description | BACKGROUND: Cancer is a complex, multiscale dynamical system, with interactions between tumor cells and non-cancerous host systems. Therapies act on this combined cancer-host system, sometimes with unexpected results. Systematic investigation of mechanistic computational models can augment traditional laboratory and clinical studies, helping identify the factors driving a treatment’s success or failure. However, given the uncertainties regarding the underlying biology, these multiscale computational models can take many potential forms, in addition to encompassing high-dimensional parameter spaces. Therefore, the exploration of these models is computationally challenging. We propose that integrating two existing technologies—one to aid the construction of multiscale agent-based models, the other developed to enhance model exploration and optimization—can provide a computational means for high-throughput hypothesis testing, and eventually, optimization. RESULTS: In this paper, we introduce a high throughput computing (HTC) framework that integrates a mechanistic 3-D multicellular simulator (PhysiCell) with an extreme-scale model exploration platform (EMEWS) to investigate high-dimensional parameter spaces. We show early results in applying PhysiCell-EMEWS to 3-D cancer immunotherapy and show insights on therapeutic failure. We describe a generalized PhysiCell-EMEWS workflow for high-throughput cancer hypothesis testing, where hundreds or thousands of mechanistic simulations are compared against data-driven error metrics to perform hypothesis optimization. CONCLUSIONS: While key notational and computational challenges remain, mechanistic agent-based models and high-throughput model exploration environments can be combined to systematically and rapidly explore key problems in cancer. These high-throughput computational experiments can improve our understanding of the underlying biology, drive future experiments, and ultimately inform clinical practice. |
format | Online Article Text |
id | pubmed-6302449 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-63024492018-12-31 High-throughput cancer hypothesis testing with an integrated PhysiCell-EMEWS workflow Ozik, Jonathan Collier, Nicholson Wozniak, Justin M. Macal, Charles Cockrell, Chase Friedman, Samuel H. Ghaffarizadeh, Ahmadreza Heiland, Randy An, Gary Macklin, Paul BMC Bioinformatics Methodology BACKGROUND: Cancer is a complex, multiscale dynamical system, with interactions between tumor cells and non-cancerous host systems. Therapies act on this combined cancer-host system, sometimes with unexpected results. Systematic investigation of mechanistic computational models can augment traditional laboratory and clinical studies, helping identify the factors driving a treatment’s success or failure. However, given the uncertainties regarding the underlying biology, these multiscale computational models can take many potential forms, in addition to encompassing high-dimensional parameter spaces. Therefore, the exploration of these models is computationally challenging. We propose that integrating two existing technologies—one to aid the construction of multiscale agent-based models, the other developed to enhance model exploration and optimization—can provide a computational means for high-throughput hypothesis testing, and eventually, optimization. RESULTS: In this paper, we introduce a high throughput computing (HTC) framework that integrates a mechanistic 3-D multicellular simulator (PhysiCell) with an extreme-scale model exploration platform (EMEWS) to investigate high-dimensional parameter spaces. We show early results in applying PhysiCell-EMEWS to 3-D cancer immunotherapy and show insights on therapeutic failure. We describe a generalized PhysiCell-EMEWS workflow for high-throughput cancer hypothesis testing, where hundreds or thousands of mechanistic simulations are compared against data-driven error metrics to perform hypothesis optimization. CONCLUSIONS: While key notational and computational challenges remain, mechanistic agent-based models and high-throughput model exploration environments can be combined to systematically and rapidly explore key problems in cancer. These high-throughput computational experiments can improve our understanding of the underlying biology, drive future experiments, and ultimately inform clinical practice. BioMed Central 2018-12-21 /pmc/articles/PMC6302449/ /pubmed/30577742 http://dx.doi.org/10.1186/s12859-018-2510-x Text en © The Author(s) 2018 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Methodology Ozik, Jonathan Collier, Nicholson Wozniak, Justin M. Macal, Charles Cockrell, Chase Friedman, Samuel H. Ghaffarizadeh, Ahmadreza Heiland, Randy An, Gary Macklin, Paul High-throughput cancer hypothesis testing with an integrated PhysiCell-EMEWS workflow |
title | High-throughput cancer hypothesis testing with an integrated PhysiCell-EMEWS workflow |
title_full | High-throughput cancer hypothesis testing with an integrated PhysiCell-EMEWS workflow |
title_fullStr | High-throughput cancer hypothesis testing with an integrated PhysiCell-EMEWS workflow |
title_full_unstemmed | High-throughput cancer hypothesis testing with an integrated PhysiCell-EMEWS workflow |
title_short | High-throughput cancer hypothesis testing with an integrated PhysiCell-EMEWS workflow |
title_sort | high-throughput cancer hypothesis testing with an integrated physicell-emews workflow |
topic | Methodology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6302449/ https://www.ncbi.nlm.nih.gov/pubmed/30577742 http://dx.doi.org/10.1186/s12859-018-2510-x |
work_keys_str_mv | AT ozikjonathan highthroughputcancerhypothesistestingwithanintegratedphysicellemewsworkflow AT colliernicholson highthroughputcancerhypothesistestingwithanintegratedphysicellemewsworkflow AT wozniakjustinm highthroughputcancerhypothesistestingwithanintegratedphysicellemewsworkflow AT macalcharles highthroughputcancerhypothesistestingwithanintegratedphysicellemewsworkflow AT cockrellchase highthroughputcancerhypothesistestingwithanintegratedphysicellemewsworkflow AT friedmansamuelh highthroughputcancerhypothesistestingwithanintegratedphysicellemewsworkflow AT ghaffarizadehahmadreza highthroughputcancerhypothesistestingwithanintegratedphysicellemewsworkflow AT heilandrandy highthroughputcancerhypothesistestingwithanintegratedphysicellemewsworkflow AT angary highthroughputcancerhypothesistestingwithanintegratedphysicellemewsworkflow AT macklinpaul highthroughputcancerhypothesistestingwithanintegratedphysicellemewsworkflow |